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Abstract 31 
Methods capable of measuring blood flow in a tissue-specific manner are needed. The purpose 32 
of this study was to investigate if contrast-enhanced ultrasound (CEUS) using bolus injections 33 
of SonoVue® is an useful method for assessing postprandial changes in microvascular 34 
perfusion in the vastus lateralis muscle. 10 healthy, young subjects were recruited for this 35 
study. 6 subjects participated in washout- and reproducibility protocols to assess washout time 36 
of SonoVue® and the reproducibility of the method when measuring microvascular blood 37 
volume (MBV). 6 subjects (two of which also participated in the washout- and reproducibility 38 
protocols) participated in exercise- and nutrition protocols, to assess the ability of the method 39 
to detect changes in MBV in response to these interventions. Intraday variation (Coefficients of 40 
variation (CV)) for MBV indices, as assessed by peak signal intensity (PI) or mean plateau signal 41 
intensity (mPI), were high (PI: 19 ± 4.2%; mPI: 23 ± 3.3%). The exercise protocol induced 42 
significant increases of MBV indices (PI:+113%, P˂0.0001; mPI:+218%, P˂0.0001) acutely after 43 
exercise cessation. There were no changes in MBV indices in response to feeding during the 44 
nutrition protocol (PI: P = 0.51; mPI: P = 0.51). We conclude that CEUS using bolus injections of 45 
SonoVue® is not capable of detecting changes in MBV of vastus lateralis in response to feeding. 46 
This is probably due to the low reproducibility of the method. However, the method is capable 47 
of measuring changes in MBV in response to exercise. This method could therefore be used 48 
when investigating exercise-induced changes in microvascular perfusion.  49 
Keywords: CEUS; Microcirculation; capillary recruitment; harmonic imaging; microbubbles; 50 
blood flow. 51 
 52 
 53 
Introduction 54 
Skeletal muscle microvascular perfusion is closely coupled to muscle metabolism. Optimal 55 
microvascular function is of major importance, due to the capillaries being the main route for 56 
delivering and exchanging nutrients, gasses, hormones etc. (Poole et al., 2013). However, 57 
investigations of the microcirculation has for many years been problematic in human subjects, 58 
due to a lack of adequate methods for accurately measures. Modern advantages in ultrasound 59 
sonography have made it possible to use contrast-enhanced ultrasound (CEUS) providing 60 
measures of microvascular blood volume (MBV) as estimates of microcirculation for 61 
investigating e.g. tissue perfusion (Wei et al., 1998). With the use of a continuous infusion of 62 
contrast agent for the CEUS recordings, studies have reported increases in skeletal muscle 63 
MBV following food intake (Keske et al., 2009; Mitchell et al., 2013; Vincent et al., 2006) and 64 
exercise (Sjøberg et al., 2011; Vincent et al., 2006). Applying a continuous infusion requires a 65 
time lapse of 5-10 min prior to assessment and an infusion pump that can handle the 66 
phosphorlipid stabilized hexafluoride microbubbles (Mitchell et al., 2013; Sjøberg et al., 2011). 67 
The infusion must ensure that the concentration of the contrast agent reaches steady state 68 
before measurements can be performed. The demands on time and equipment raised by this 69 
method may be challenging in some experimental settings and it would therefore be beneficial 70 
if CEUS could be performed using a single-bolus injection of contrast-agent. 71 
To date, two studies has, to these author´s knowledge, reported the reproducibility of CEUS 72 
using bolus injections of contrast agent for investigating skeletal muscle microvascular 73 
perfusion (Mulder et al., 2008; Tobin et al., 2010). Both of these studies used the contrast 74 
agent SonoVue®(Mulder et al., 2008; Tobin et al., 2010).  75 
Mulder and colleagues were the first to do CEUS recordings on skeletal muscle using bolus 76 
injections of SonoVue® and they derived their protocol based on continuous infusion protocols 77 
(Mulder et al., 2008). Following the bolus injection, a high mechanical index (MI) flash was 78 
used to destroy the microbubbles within the region of interest (ROI). The reproducibility of the 79 
technique was investigated during resting measurements of MBV and microvascular flow 80 
velocity (MFV) in the muscles of the forearm. MBV was found to have an acceptable 81 
reproducibility, with a coefficient of variation (CV) of 11%, whereas MFV was found to have 82 
poor reproducibility (CV=256%). Furthermore, Mulder and colleagues used the technique to 83 
demonstrate changes in MBV in response to hyperinsulinemia and exercise (Mulder et al., 84 
2008). 85 
Tobin and colleagues investigated the reproducibility of CEUS recordings on abdominal skeletal 86 
muscle and subcutaneous adipose tissue using bolus injections of SonoVue® (Tobin et al., 87 
2010). In this study, a high MI flash was not performed. Instead, 4-minutes real-time imaging 88 
was recorded from the time of injection. Using this protocol, the researchers used the first 89 
phase plateau as an index of MBV. These measurements had a CV of 4%, indicating a good 90 
reproducibility in determining MBV in both skeletal muscle and subcutaneous adipose tissue 91 
(Tobin et al., 2010). The researchers also investigated changes in MBV in subcutaneous adipose 92 
tissue and forearm skeletal muscle in response to an oral glucose load and found an increase 93 
of MBV in adipose tissue but not in forearm skeletal muscle (Tobin et al., 2010). This finding is 94 
in contrast with earlier findings, reporting increases of 40-70% in muscle MBV following a 95 
mixed meal, where it was measured by CEUS using a continuous infusion protocol (Keske et al., 96 
2009; Vincent et al., 2006). Therefore, it still remains unclear if CEUS using bolus injections of 97 
SonoVue® is capable of detecting changes in MBV of skeletal muscle in response to ingestion 98 
of a mixed meal. 99 
In the present study we investigated if CEUS using bolus injections of SonoVue® is reliable and 100 
a useful method for assessing postprandial changes in microvascular perfusion in the vastus 101 
lateralis muscle. As numerous studies have shown large increases in MBV and MFV in response 102 
to exercise (Inyard et al., 2007; Krix et al., 2010; Rattigan et al., 2005; Sjøberg et al., 2011; St-103 
Pierre et al., 2012; Vincent et al., 2006), exercise was used as a positive control for the 104 
detection of changes in these parameters.   105 
Methods 106 
Participants 107 
A total of 10 young, healthy subjects (3 women and 7 men, 24.3 ± 3.3 years, BMI; 21.6 ± 1.6 108 
kg/m2, systolic blood pressure; 125 ± 8.8 mmHg, diastolic blood pressure; 69.3 ± 8.7 mmHg, 109 
resting heart rate; 57.9 ± 11.0 beats/min [Mean ± SD]) were recruited through advertisements 110 
on social media. Following exclusion criteria were used; BMI ˃25, smoking, heart disorders, 111 
diabetes and daily or frequent intake of medication (oral contraceptives were allowed). 112 
In all protocols, subjects gave written informed consent. The study was performed according 113 
to the declaration of Helsinki II and was approved by the local ethics committee of the Capital 114 
Region of Denmark (journal H-4-2014-112).  115 
Standard preparation 116 
All protocols were performed at ~8 am, with subjects arriving to the hospital in the overnight 117 
fasted state. Subjects were instructed to refrain from alcohol, caffeine and strenuous activities 118 
the day before each trial. Upon arrival to the hospital, the subject was weighed, placed 119 
comfortably in the supine position in a bed, and the antecubital vein was catheterized (18 G 120 
Venflon, Becton Dickinson, Helsingborg, Sweden). For all protocols, subjects rested in the 121 
supine position for 30 minutes before the first CEUS recording was performed. After 20 122 
minutes of rest, blood pressure and heart rate were measured on the contralateral arm.  123 
Contrast-enhanced ultrasound protocol 124 
During the 30 minutes of rest, B-mode imaging was used to find a fixpoint approximately at 125 
the mid-portion of the right m. vastus lateralis. Upon determination of an appropriate fixpoint, 126 
the precise transducer placement was marked on the skin of the subject and thigh 127 
characteristics were drawn on transparent to ensure that the exact same tissue volume was 128 
scanned during each recording (inter- and intraday).  129 
The ultrasound gel thickness applied, prevented any pressure of the transducer on the 130 
underlying tissue. The contrast agent dry matter (SonoVue®, Bracco S.p.A, Italy) was dissolved 131 
in sterile saline and mixed gently for exactly 30 sec before injection. SonoVue® is a suspension 132 
of phospholipid-stabilized microbubbles filled with sulphur hexafluoride and is diluted in 4.5 ml 133 
0.9% saline solution before injection (8 µl microbubbles ml-1).  A bolus of 2.0 ml SonoVue® was 134 
injected through the antecubital vein followed by an immediate flush of 10 ml 0.9% saline 135 
solution. SonoVue® contains microbubbles of different sizes, ranging between diameters of 1 136 
µm to 10 µm, with a mean of 2.5 µm. The size of the microbubbles is small enough to allow 137 
free passage through the capillaries, but large enough to retain in the vascular system (Greis, 138 
2004). Therefore the microbubbles will be distributed throughout the entire blood volume, but 139 
will not diffuse into the extracellular fluid space (Greis, 2004). After leaving the microbubbles, 140 
the gas is exhaled through the lungs, and therefore does not interfere with renal or hepatic 141 
excretion pathways (Greis, 2004). 142 
All ultrasound scannings were done by the same investigator, using a handheld linear array 143 
transducer (L9-3MHz) and an iU22 ultrasound scanner (Phillips Medical Systems, Bothell, USA). 144 
Contrast first harmonic signals were received at 8 MHz with a mechanical index of 0.06. For all 145 
subjects, depth was set at 3 cm (except for one subject in protocol A, where depth was 146 
increased to 3.5 cm), allowing measurements of the full depth of the m. vastus lateralis. Gain 147 
was set at 90% for each recording. Focus was optimized and standardized for each subject 148 
when finding the fix point. Twenty millisecond images were captured consecutively for 2 149 
minutes following each bolus injection. 150 
Study design 151 
The study was divided in 3. First, we performed the washout protocol to determine the 152 
washout time of SonoVue® microbubbles. Thereafter we wanted to investigate intra- and 153 
interday reproducibility of the method in the reproducibility protocol. Third, we investigated 154 
the ability of the method to detect changes in microvascular perfusion induced by either 155 
exercise or nutrition, investigated by separate protocols (A1 and A2, B1 and B2). 156 
Image analysis 157 
Image analysis was performed offline using an ultrasound quantification and analysis software 158 
(QLAB, Phillips Medical Systems). Image analysis was performed by a blinded investigator. 159 
Region of interest (ROI) for analysis was set to include as much as m. vastus lateralis as 160 
possible, excluding larger vessels, connective tissue and artefacts appearing on the image 161 
In a ROI, we measured peak signal intensity (PI [dB]), background signal intensity (BI [dB]) and 162 
mean first phase plateau signal intensity (mPI [dB]). These measurements are described in 163 
detail below. 164 
PI and mPI were used as indices of MBV. Both PI and mPI were measured including (A+B) and 165 
excluding background signal (A). PI was defined as the highest measured signal intensity in 166 
response to the bolus injection. mPI was defined as the mean signal intensity during the first 167 
phase plateau after the peak of wash-in curve. A plateau in signal intensity was defined as a 168 
period of minimum 10 seconds where the signal intensity did not change noticeably. BI was 169 
calculated as the mean signal before the onset of the wash-in curve. 170 
Protocol A: Determination of washout period and reproducibility 171 
Subject characteristics 172 
Six healthy, young volunteers (3 men, 3 women, age 24 ± 4.3 years, body mass index 21 ± 4.0 173 
kg/m2, Systolic blood pressure 129 ± 12 mmHg, diastolic blood pressure 72 ± 18 mmHg, Resting 174 
heart rate 63 ± 20 beats/min [mean ± SD]) took part in this protocol.  175 
A1: Washout protocol 176 
In this protocol, we performed a single CEUS recording as described in section Standard 177 
preparation at time zero. Subjects arrived at the hospital at time point -30 min and remained 178 
in the supine resting position until time point 0 min To detect the minimum time required 179 
before microbubbles were no longer detectable in the scanned area, 60 s ultrasound 180 
recordings were captured at 10, 15, 20, 30, 40 minutes post injection (See fig. 1a).  181 
A2: Reproducibility protocol 182 
At this point we had determined the washout period, and therefore we knew the minimum 183 
time before the CEUS protocol could be repeated.  184 
To test the intraday reproducibility of the method, three CEUS recordings were performed as 185 
described in section Standard preparation. Based on the findings from protocol A1 (See 186 
Results), washout intervals of 15 minutes were used between measurements (see fig. 1b). To 187 
test the interday reproducibility of the method, the protocol illustrated at fig. 1b was repeated 188 
twice within 3-7 days after the washout protocol. 189 
Protocol B; Microvascular responses to exercise or nutrition 190 
Subject characteristics 191 
Six healthy, young volunteers (5 men, 1 woman, age 25 ± 4.2 years, body mass index 22 ± 1.0 192 
kg/m2, Systolic blood pressure 121 ± 9.0 mmHg, diastolic blood pressure 66 ± 7.0 mmHg, 193 
Resting heart rate 52.7 ± 11 beats/min [mean ± SD]) took part in this protocol. Two of the 194 
subjects had also participated in protocol A.  195 
Protocol B1 - Nutrition 196 
In this protocol we investigated whether the method was capable of detecting changes in 197 
microvascular perfusion in response to feeding. A baseline CEUS recording was performed at 198 
time point -15 minutes, as described in section Standard preparations. Thereafter, the subject 199 
consumed a drink in less than 5 min containing 20 g whey protein hydrolysate (Peptigen IF-200 
3090, Arla Foods Ingredients P/S, Viby J, DK) and 80 g maltodextrin (Fagron Nordic A/S, 201 
Copenhagen, DK) at time point 0. The subjects were allowed to sit upright when consuming 202 
the drink, but remained in the supine position throughout the rest of the protocol. CEUS 203 
recordings were performed again at time points 30 and 60 minutes The experimental protocol 204 
is illustrated in fig. 1c. 205 
Strength testing 206 
Strength testing was performed on the same day as the nutrition protocol, after the last CEUS 207 
recording had been performed. Subjects had their 1 RM determined on their right leg in a leg 208 
extension machine (Cybex®, UK). After warming up on light loads, subjects would perform 2 209 
repetitions on gradually increasing loads interspersed with sufficient rest periods. When the 210 
subject was capable of 1 but not 2 repetitions, the load was noted given the 1 RM.  211 
Protocol B2 - Exercise 212 
This protocol was performed 4-7 days after protocol B1, and is illustrated in fig. 1d. Subjects 213 
were placed supine on the hospital bed at time point -45 min. At time point -15 min a baseline 214 
CEUS recording was performed as described in section Standard preparations. Subjects were 215 
then placed in the leg extension equipment. At time point 0 min, the subjects would then 216 
perform 3 sets of 10 repetitions of unilateral leg extensions with their right leg at 70% of their 217 
1 RM. Sets were interspersed with 1 min rest. Immediately after completion of the exercise 218 
bout, subjects were placed in the supine position on the hospital bed, and a CEUS recording 219 
was performed as soon as possible. All CEUS recordings were initiated within 1 minute after 220 
exercise cessation.  221 
Statistics 222 
In the wash-out protocol, one-way ANOVA and Holm-Sidak´s multiple comparisons test was 223 
used to evaluate differences in signal intensities for baseline (signal intensity prior to the onset 224 
of the wash-in curve of the bolus), mean signal intensity during the bolus curve (mean of signal 225 
intensity after onset of the wash-in curve until termination of the recording), and mean signal 226 
intensity during the 60 seconds recordings at 10, 15, 20, 30 and 40 minutes post injection.   227 
The reproducibility of the contrast-enhanced ultrasound technique was assessed by calculation 228 
of the standard deviation and the corresponding coefficient of variation (CV). CVs were 229 
calculated both for intra- and interday measurements using the formula CV = SD/mean.  230 
Intraday CVs were calculated for each subject from the variation of the parameters obtained 231 
through the CEUS recordings from the 2 reproducibility protocols. Intraday CVs were obtained 232 
for both reproducibility protocol day 1 and 2. The average of these two CVs was used as the 233 
intraday CV for the subject, and used for the calculation of the mean CV for all subjects. 234 
Interday CVs were calculated using the CEUS recording from the washout protocol and the 235 
CEUS recordings at time point 0 form the 2 reproducibility protocols. Furthermore, we tested 236 
the effect of bolus injection number by one-way ANOVA and Holm-Sidak´s multiple 237 
comparisons test.  238 
In the intervention protocols, one-way ANOVA and Holm-Sidak´s multiple comparisons test 239 
were used to evaluate changes in the measured parameters from baseline to the measured 240 
time point. P < 0.05 was considered statistically significant. All data are reported as mean ± 241 
SEM, except subject characteristics, which are presented as mean ± SD. 242 
Results 243 
Washout protocol 244 
To investigate the washout-period of the SonoVue® contrast-agent, we compared mean 245 
baseline signal intensity, mean signal intensity during the bolus curve recorded after the 246 
injection, and mean signal intensity at 10, 15, 20, 30 and 40 minutes post injection (Fig 2). 247 
Mean signal intensity immediately following bolus injection was significantly higher than mean 248 
baseline intensity (Baseline; 15.7 ± 0.2 dB, bolus mean; 17.0 ± 0.3 dB, P<0.05). Mean signal 249 
intensities at 10, 15, 20, 30 and 40 minutes post injection were not significantly different from 250 
baseline signal intensity. Based on these findings, we decided that a 15 minute washout period 251 
was sufficient before injections could be repeated in later protocols. 252 
Reproducibility protocol 253 
To test the reproducibility of the method, we performed CEUS assessments of three occasions 254 
with three injections interspersed with 15 minute intervals. We compared two methods for 255 
estimating MBV; peak signal intensity and first phase plateau intensity. Mean background 256 
signal was 15.7 dB ± 0.5 dB, mean peak intensity was 17.1 ± 0.8 dB and mean first phase 257 
plateau intensity was 16.7 ± 0.7 dB. The coefficient of variation (CV) for measurements 258 
including background signal (A + B) were for intraday comparisons (PI CV; 1.8 ± 0.4%, mPI CV; 259 
1.4 ± 0.2%) and interday comparisons (PI CV; 2.9 ± 0.9%, mPI CV; 1.8 ± 0.4). When assessing 260 
the signal alone (A) the intraday variation was (PI CV: 19 ± 4.2%; mPI CV: 23 ± 3.3) and interday 261 
variation was (PI CV: 27 ± 9.8%; mPI CV: 31 ± 7.3%) (Table 1). Paired t-test did not show 262 
significant difference between the CVs of PI and mPI when comparing intraday or interday 263 
measurements (P=0.15 and P=0.59, respectively). Interday variation was not significantly 264 
different from intraday variation for any of the measured parameters (PI: P=0.48 and mPI: 265 
P=0.38). 266 
Intervention protocol 267 
All-subject mean curves for exercise and nutrition intervention are illustrated in fig. 3 and 4 268 
and the results from the intervention protocols are summed up in table 2. 269 
Average 1 RM in the one legged knee extension exercise was 47.4 ± 14.7 kg, resulting in an 270 
average exercise load of 33.1 ± 9.1 kg in 3 sets of 10 knee extension reps at 70% 1RM. Exercise 271 
induced acute changes in peak signal intensity (+113%, P˂0.001), plateau intensity (+218%, 272 
P˂0.001) compared to baseline measurements. All CEUS recordings acutely after exercise 273 
cessation exhibited double peaks in signal intensity (as seen in the all-subject mean bolus 274 
curve, fig 3).  275 
During the nutrition protocol, there was no effect of time on neither peak intensity (P = 0.51) 276 
nor plateau intensity (P = 0.51). 277 
Discussion 278 
The present study demonstrates that CEUS using bolus injections of SonoVue appears to be as 279 
reliable as existing techniques  for assessing microvascular blood volume in vastus lateralis 280 
muscle. This conclusion is based on the finding that the coefficient of variation for our chosen 281 
indices of microvascular blood volume (MBV) were comparable to what has been observed in 282 
earlier studies using CEUS in other muscles (Mulder et al., 2008; Tobin et al., 2010). 283 
Furthermore, we were able to detect and demonstrate that exercise significantly increased 284 
microvasular blood volume acutely after exercise, whereas we could not detect any change in 285 
the immediate postprandial period. 286 
Reproducibility 287 
To assess intra- and interday reproducibility of the CEUS method, we performed repeated 288 
measurements during resting conditions on the same day, as well as on different days, 289 
respectively. There was no difference in intra- and interday reproducibility when using peak 290 
intensity or mean plateau intensity for measuring MBV. The bolus curves obtained in this study 291 
was very different between subjects, with some bolus curves exhibiting a good plateau phase, 292 
while others had no clear plateau phase. This difference between bolus curves could 293 
potentially cause data interpretation to be highly investigator-dependent. In the present study, 294 
bolus curves were analyzed by a blinded investigator, which we suggest is crucial for this type 295 
of data analysis. As peak intensity represents the highest signal intensity obtained in the bolus 296 
curve, this method for estimating MBV is not investigator-dependent. Our findings therefore 297 
indicate that peak signal intensity could be used instead of mean plateau intensity when 298 
measuring MBV by CEUS using bolus injections of SonoVue®. The coefficient of variation (CV) 299 
of our measurements of peak signal intensity and plateau signal intensity were comparable to 300 
that observed in prior studies  (Mulder et al., 2008; Tobin et al., 2010). Tobin and colleagues 301 
reported a CV of 4% while Mulder and colleagues found a CV of 11% when measuring signal 302 
intensity including background signal (A+B) (Mulder et al., 2008; Tobin et al., 2010). Compared 303 
to these studies, we found a numerically lower CV (1.4%). However, as changes in 304 
microvascular blood volume in response to vasodilatory stimuli are assessed by the ratio of A 305 
from the intervention and A obtained from baseline recordings, the reproducibility of the 306 
parameter A by itself is therefore more relevant than when combined with B, being the 307 
background noise of the probe without presence of microbubbles, as the parameter A+B. B is 308 
very large compared to A, and will contribute minimally to the variation of the total signal 309 
(A+B). This effectively causes a slightly larger SD to be divided by a far larger mean signal 310 
intensity, thereby lowering the CV. Therefore, we suggest that the CV of the actual 311 
measurement should be given only by including the A parameter. We got a CV here on 19% for 312 
peak signal intensity and 23% for plateau signal intensity. We cannot though, compare the 313 
reproducibility of our method with CEUS using a bolus injection protocol to CEUS using a 314 
continuous infusion protocol as there are no available studies reporting the reproducibility of 315 
the latter protocol. 316 
To assess interday reproducibility of the method, we compared measurements obtained on 317 
three separate days under comparable conditions. When being very thorough with identifying 318 
and repeating the scannings at the same area and ROI, we found that CVs for peak signal 319 
intensity (27%), plateau signal intensity (31%) were not significantly different for interday 320 
measurements compared to intraday measurements. These results indicate that 321 
reproducibility of the method is not compromised when comparing recordings obtained at 322 
different days. Weber and colleagues (Weber et al., 2006) found that signal intensity obtained 323 
through the use of CEUS recordings (with a continuous infusion protocol) in resting subjects 324 
correlated with capillary fiber contacts in human skeletal muscle. Capillarization increases over 325 
the course of a prolonged training period by 10-50% in the number of capillaries per fiber 326 
(Hoier and Hellsten, 2014). Therefore, although CEUS could potentially be used as a method of 327 
estimating changes in capillarization after e.g. a training protocol. the CEUS method as 328 
performed in this study probably does not have the required interday reproducibility to detect 329 
such changes.  330 
Intervention protocols 331 
Having verified the reproducibility of the CEUS measurement using a bolus injection, we 332 
performed experiments to investigate if the method was capable of detecting acute changes in 333 
microvascular perfusion in response nutrition. Furthermore, we used exercise as a positive 334 
control, to investigate if the method was capable of detecting larger changes in MBV. Hence, 335 
we performed CEUS recordings after intake of a protein-carbohydrate drink, and after the 336 
execution of one-legged knee extension exercise.  337 
The positive control, knee extensor exercise, induced a large increase in MBV, as indicated by 338 
increases in peak signal intensity (+113%) and plateau signal intensity (218%) acutely after 339 
exercise cessation.  Due to a lack of any gold standard method of measuring MBV it is not 340 
possible to determine which of our parameters for MBV (peak signal intensity or plateau signal 341 
intensity) that gives the most accurate estimate. Using the continuous infusion protocol, 342 
Sjøberg and colleagues (Sjøberg et al., 2011) found that MBV increased 310% in response to 343 
one legged knee extensor exercise at 25 W for 10 min. Vincent and colleagues (Vincent et al., 344 
2006) found that MBV increased approximately ~200% in the muscles of the forearm in 345 
response to high-intensity isometric handgrip exercise. Even though our results cannot be 346 
directly compared with the above mentioned results due to differences in exercise protocols 347 
and muscles investigated, our results seem to be in agreement with prior studies and CEUS 348 
recordings using bolus injection can presumably be used for assessing changes in muscle blood 349 
volume in response to acute exercise. 350 
Surprisingly, we were not able to detect any changes in MBV in response to feeding. Tobin and 351 
colleagues were also not able to detect any changes in MBV in response to a 75 g glucose load 352 
(Tobin et al., 2010), which is in contrast with prior CEUS studies (Churchward-Venne et al., 353 
2014; Keske et al., 2009; Mitchell et al., 2015, 2013; Timmerman et al., 2012; Vincent et al., 354 
2006). However, most of the latter studies have assessed microvascular perfusion via CEUS 355 
using a continuous infusion of contrast agent. Tobin and colleagues suggested that the lack of 356 
effect of their feeding protocol on MBV could be due to the feeding stimulus being 357 
inadequate. In the present study however, the feeding stimulus was comparable to that of the 358 
studies showing an effect of feeding on MBV. Therefore, it seems unlikely that the lack of an 359 
effect of feeding on microvascular perfusion in our study is due to an insufficient feeding 360 
stimulus. Instead, the lack of an effect is probably due to the either inadequacy of the method 361 
to detect the changes, or no effect of feeding on MBV in our subjects. As insulin has been 362 
many times to act as a vasodilator in healthy subjects (Dawson et al., 2002; Sjøberg et al., 363 
2011; Timmerman et al., 2010; Vincent et al., 2002), and given that an effect of feeding on 364 
MBV in skeletal muscle has been detected in many studies prior to ours, the lack of an effect 365 
observed in the present study is likely due to an inadequate sensitivity of our method. Prior 366 
studies have found postprandial increases in MBV of 36-67% (Keske et al., 2009; Mitchell et al., 367 
2015, 2013; Vincent et al., 2006).We found an intraday variation for our MBV indices of 19-368 
23%, which therefore might be inadequate in order to detect an effect in the lower range of 369 
what has been observed in earlier studies. As there is no golden standard method for assessing 370 
microvascular perfusion, it is difficult to verify the validity of our results. Approaching the limit 371 
of detection with the bolus injection approach of micobubbles, it would have been valuable to 372 
have other measurements of blood flow by e.g. measuring leg blood flow to investigate of 373 
feeding had any effect on total perfusion of the leg. However, prior investigations have 374 
observed that changes in total leg blood flow are delayed compared to changes in 375 
microvascular blood flow (Mitchell et al., 2015, 2013) and hence the microvascular blood flow 376 
and blood volume changes are likely to be due to resdistribution of microvascular flow(Clark et 377 
al., 2006). Changes in a. femoralis blood flow might therefore not be indicative of changes in 378 
microvascular perfusion. Alternatively, it would have been interesting to look into the 379 
sensitivity of the method by applying a dose-response investigation of vasodilator substances 380 
and measuring changes in MBV, and thereby investigate the ability of the method to detect 381 
smaller changes in MBV..  382 
In conclusion, we found that CEUS using bolus injections of SonoVue appears to be as reliable 383 
as existing techniques  for assessing microvascular blood volume in the vastus lateralis muscle. 384 
However, our results also demonstrate that CEUS using bolus injections of SonoVue® is not 385 
capable of detecting changes in skeletal muscle microvascular perfusion in response to 386 
feeding, likely due to the method having inadequate sensitivity. Given that a large number of 387 
prior studies have detected postprandial changes in MBV using continuous infusion protocols 388 
of contrast agent (Keske et al., 2009; Mitchell et al., 2013; Vincent et al., 2006), we therefore 389 
recommend to use such a protocol if feeding-induced changes in microvascular perfusion is of 390 
interest. Our method was capable of detecting changes in microvascular perfusion in response 391 
to exercise, and could therefore potentially be used if exercise induced changes in 392 
microvascular perfusion is of interest. 393 
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TABLE 1 477 
 478 
 479 
 480 
TABLE 2 481 
 482 
  483 
                      Intraday CV (%)                          Interday CV (%)
Peak intensity Plateau intensity Peak intensity Plateau intensity
A 19 ± 4.2 23 ± 3.3 27 ± 9.8 31 ± 7.3
A + B 1.8 ± 0.4 1.4 ± 0.2 2.9 ± 0.9 1.8 ± 0.4
Baseline 0 min Baseline 30 min 60 min
Peak intensity (dB) 1.7 ± 0.1 3.6 ± 0,1* 1.3 ± 0.2 1.1 ± 0.1 1.1 ± 0.1
Plateau intensity (dB) 0.9 ± 0.1 2.7 ± 0.1* 0.9 ± 0.1 0.8 ± 0 0.9 ± 0.1
Exercise protocol Nutrition protocol
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